Fractures: Clinical Trials

11 trials for Fractures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 not yet recruiting, 1 terminated. 11 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 7, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 32Completed 1, Terminated 1
Phase 11Completed 1

Follow Fractures: new trials by email Literature Review of Fractures trials Research Report on Fractures

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Local Iloprost Therapy to Promote Bone Healing in High Risk Fractures
Ilomedin, Normal saline placebo - Nonunion Bone Fracture, Fractures Ununited
Phase 2Not yet recruitingCharite University, Berlin, Germany602027-01-012026-11-09
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
Lithium Carbonate, Lactose Placebo - Fractures
Phase 2UnknownSunnybrook Health Sciences Centre1602017-07-212024-01-26
Bone Mass and Strength After Kidney Transplantation
Vitamin D3, Calcitriol, Placebo - End Stage Renal Disease, Kidney Transplantation
Phase 2CompletedColumbia University612014-08-182025-03-07
Musculoskeletal Effects of Bicarbonate
potassium bicarbonate, Inactive placebo capsule - Muscle Loss, Fractures
Phase 2CompletedTufts University2442012-01-012015-10-19
Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial
Polycaprolactone / Tri-Calcium Phosphate, Titanium Mesh - Fractures, Enophthalmos
Phase 2UnknownNational University Hospital, Singapore802010-04-012014-04-28
Low-magnitude High-frequency Vibration Study on Fracture Rate in Community Elderly
Low-magnitude high-frequency vibration treatment - Fractures
Phase 2 / Phase 3CompletedChinese University of Hong Kong7042009-01-012012-04-24
A Study of rhBMP-2/CPM in Closed Fractures of the Humerus
rhBMP-2/CPM - Fractures
Phase 2CompletedWyeth is now a wholly owned subsidiary of Pfizer1392007-01-012013-02-28
Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures
rhBMP-2/CPM, surgical intervention alone - Fractures
Phase 2CompletedWyeth is now a wholly owned subsidiary of Pfizer1082006-12-012013-02-28
A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures
rhBMP-2/CPM - Fractures
Phase 2 / Phase 3TerminatedWyeth is now a wholly owned subsidiary of Pfizer3672006-11-012013-02-28
Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling
FallSaver (formerly called NOCwatch) - Accidental Falls, Fractures
Phase 1 / Phase 2CompletedNOCwatch International502004-12-012006-05-29
Therapeutic Touch for Wrist Fractures in Postmenopausal Women
Therapeutic Touch - Osteoporosis, Fractures
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1252003-03-012006-08-17

Narrower conditions

Fractures, Bone (11)  ·  Osteoporosis (2)  ·  Bone Diseases, Metabolic (1)  ·  Callosities (1)  ·  Diplopia (1)  ·  Enophthalmos (1)  ·  Fractures, Ununited (1)  ·  Hyperparathyroidism (1)  ·  Kidney Failure, Chronic (1)  ·  Muscular Atrophy (1)  ·  Vascular Calcification (1)  ·  Wounds and Injuries (1)

Broader conditions

Wounds and Injuries (10)  ·  Bone Diseases (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Bone Diseases, Metabolic (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Signs and Symptoms (2)  ·  Atrophy (1)  ·  Calcinosis (1)  ·  Calcium Metabolism Disorders (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)

Interventions

Calcitriol (1)  ·  Cholecalciferol (1)  ·  Lithium (1)  ·  Lithium Carbonate (1)  ·  Surgical Procedures, Operative (1)  ·  Therapeutic Touch (1)  ·  potassium bicarbonate (1)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (3)  ·  Charite University, Berlin, Germany (1)  ·  Chinese University of Hong Kong (1)  ·  Columbia University (1)  ·  NOCwatch International (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National University Hospital, Singapore (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  Tufts University (1)

Countries

United States (7)  ·  Canada (4)  ·  Australia (3)  ·  Finland (3)  ·  France (3)  ·  Germany (3)  ·  Sweden (3)  ·  Brazil (2)  ·  Mexico (2)  ·  Norway (2)  ·  Romania (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  China (1)  ·  Hungary (1)

Top investigators

Bess Dawson-Hughes, M.D. (1)  ·  Dennis Clifton, PharmD (1)  ·  Diane Nam, MSc,MD,FRCSC (1)  ·  Karen M. Prestwood, MD (1)  ·  Kathryn E Kelly, DrPH (1)  ·  Kwok-Sui Leung, MD (1)  ·  Marcel Niemann, PD Dr. med. (1)  ·  Thiam Chye Lim, MD (1)  ·  Thomas Nickolas, MD, MS (1)

Results publications

PMID 24676848, PMID 28842733, PMID 29211866, PMID 31915160, PMID 35727196

NIH funding

R01AR060261 (1)